Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dal Bello, F., & Hertel, C. (2006). Oral cavity as natural reservoir for intestinal lactobacilli. Systematic and Applied Microbiology, 29(1), 69–76.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health:
Positive
Source: human faeces, blood and fermented foods
DNA G+C(%): 42-44
|
Opt. T: 30-34℃
Low T(℃): 2(d)
Lower T(℃): 20(+)
Mid T(℃): 37(+)
High T(℃): 45(neg)
NaCl 3-5%: 5(+)
NaCl >6%: 10(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
oxacillin: R(16-64)
penicillin: SensRNG: (0.5-4)
|
cefotaxime: SensRNG: (0.125-1)
|
streptomycin: R(16-64)
tobramycin: RNG: (2-8)
|
erythromycin: Var(MIC50): 4, MIC90: 32, RNG: (0.25-256)
|
ofloxacin: RNG: (8-16)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
tetracycline: R(MIC50): 16, MIC90: 256, RNG: (2-512)
|
vancomycin: R(≥256-)
|
|
chloramphenicol: SensRNG: (1-4)
nitrofurantoin: R(128-≥256)
|
clindamycin: RNG: (8-64)
lincomycin: RNG: (0.5-16)
novobiocin: RNG: (4-32)
|